← Leaderboards
Eneda Toska
Johns Hopkins University
$2,070,381
Attributed
$2,070,381
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $523.2K · FY2021–25$1M$750K$500K$250K$0
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$2,070,381 · 3
By mechanism
R01$1,105,006 · 1
K22$527,286 · 1
R21$438,089 · 1
Top collaborators
No co-investigators on record.
Most similar at Johns Hopkins University
Same institution · by research overlap
- Craig Fletcher$3,491,197
- Charles George Eberhart$6,496,191
- Ie-Ming Shih$14,895,140
- Ben H Park$14,510,999
- Margaret Daniele Fallin$44,276,916
Others in their field
Other Emerging Leaders on “Resistance”
- John Damon Chodera · Sloan-Kettering Inst Can Research$56,843,703
- Urs Ochsner · Crestone, Inc.$40,390,611
- Ryan Cirz · Revagenix, Inc.$40,209,479
- Nancy Roche · Leidos Biomedical Research, Inc.$39,999,252
- Michael Dignam · National Institute Of Allergy And Infectious Diseases$30,845,607
- Daniel Pevear · Venatorx Pharmaceuticals, Inc.$24,789,028
Research focus
ResistanceChromatinMammary NeoplasmsPlayHormone TherapyGrowthGenetic TranscriptionMalignant Breast NeoplasmMutantOrganoidsResponseTumorMutationEpigenetic ProcessAffectEstrogen ReceptorsCellsBreastMediatingCancer EtiologyEpigenomicsDrug ResistanceAdvanced Prostate CancerEnhancers
Grant awards (8)
Mechanisms by which histone methyltransferases regulate nuclear receptor activity and response to therapy in hormone-driven tumors.$374,578
R01 · FY2025 · CA · contact PI
Mechanisms by which histone methyltransferases regulate nuclear receptor activity and response to therapy in hormone-driven tumors.$355,850
R01 · FY2024 · CA · contact PI
Mechanisms by which histone methyltransferases regulate nuclear receptor activity and response to therapy in hormone-driven tumors.$374,578
R01 · FY2023 · CA · contact PI
Mechanisms of epigenetic regulation of estrogen receptor function in breast cancer$148,622
K22 · FY2023 · CA · contact PI
Mechanisms of epigenetic regulation of estrogen receptor function in breast cancer$190,864
K22 · FY2022 · CA · contact PI
Elucidating the role of the SWI/SNF complex in mediating hormone therapy resistance in breast cancer$188,371
R21 · FY2022 · CA · contact PI
Elucidating the role of the SWI/SNF complex in mediating hormone therapy resistance in breast cancer$249,718
R21 · FY2021 · CA · contact PI
Mechanisms of epigenetic regulation of estrogen receptor function in breast cancer$187,800
K22 · FY2021 · CA · contact PI